Molecular Biology Enzymes and Kits & Reagents Market based on by Product (Kits and Reagents, Enzymes, Polymerases, Ligases, Restriction Endonucleases, Reverse Transcriptases, Others), by Application (Polymerase Chain Reaction, Sequencing, Cloning, Epigenetics, Restriction Digestion, Synthetic Biology, Others) and by End Users (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Centers, Others),Regional Outlook– Global Forecast up to 2030
Gene mutations are significant in the aetiology and progression of illnesses and disorders such as immune system disorders, metabolic diseases, cancer, and in-born genetic disorders. As a result, researchers may use extensive knowledge of the human genome to better understand the aetiology of certain disorders and devise treatment regimens. The growing number of genome projects throughout the world, along with lower genetic analysis costs, aids in the advancement of research in areas such as illness treatment, personalised medicine, and microbial genetics. These procedures necessitate the employment of numerous molecular biology enzymes and reagents, and as a result, the molecular biology enzymes and kits & reagents market is predicted to grow.
Genomic research has grown as a scientific study subject during the last two decades. The genomics sector has seen major technical advances as a result of grants and financing from government entities. R&D investments have given chances for expansion in the molecular biology enzymes and kits & reagents markets. China is one of the world's top R&D investors, with the country likely to surpass the United States in R&D spending by 2023 (Source: Council on Foreign Relations or CFR). As a result, several corporations have expanded their operations and R&D efforts in China. In 2020, the country's R&D investment is expected to increase from 10.3% to USD 378 billion (2.44 trillion Chinese yuan).
However, reimbursement regulations for genetic testing are rigid. Unless authorised by a physician, most health insurance plans in the United States do not cover the cost of genetic testing. Coverage and reimbursement are completely determined by the provider's policy. For example, Medicare covers genetic testing for persons with cancer who qualify for Medicare coverage of genetic testing for an inherited mutation. Such worries are stifling market expansion throughout the world.
The segmentation coverage of the study is provided below.
Molecular Biology Enzymes and Kits & Reagents Market based on Product
Previously, North America led the worldwide Molecular Biology Enzymes, Kits, and Reagents market, with Europe close behind. Factors contributing to North American market domination include the availability of cutting-edge technology and the presence of better research institutes for R&D on enzymes and reagents. However, the expanding number of life science and drug discovery research, as well as important improvements in health and medicine in emerging nations, are expected to assist Asia Pacific grow significantly throughout the projection period.
The competitive landscape for molecular biology kits and reagents gives information by competitor. Company overview, financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance are all included. The data points shown above are only linked to the firms' concentration on the molecular biology kits and reagent sector.
Thermo Fisher Scientific, Inc., LGC Limited, Merck KGaA, Promega Corporation, New England Biolabs, Illumina, Inc., Takara Bio Inc., Qiagen, FUJIFILM, and others are among the prominent competitors profiled in the molecular biology kits and reagent market research. Among the local and worldwide companies are Wako Pure Chemical Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Sigma-Aldrich Co., Bio-Rad Laboratories, Inc., Bio Basic Inc., Jena Bioscience GmbH, BD, Abbott, Beckman Coulter, Inc., Life Technologies, and MBR, Inc. Global, North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America market share statistics are accessible individually. Analysts at DBMR evaluate competitive strengths and conduct competitive analysis for each rival individually.
Genomic research has grown as a scientific study subject during the last two decades. The genomics sector has seen major technical advances as a result of grants and financing from government entities. R&D investments have given chances for expansion in the molecular biology enzymes and kits & reagents markets. China is one of the world's top R&D investors, with the country likely to surpass the United States in R&D spending by 2023 (Source: Council on Foreign Relations or CFR). As a result, several corporations have expanded their operations and R&D efforts in China. In 2020, the country's R&D investment is expected to increase from 10.3% to USD 378 billion (2.44 trillion Chinese yuan).
However, reimbursement regulations for genetic testing are rigid. Unless authorised by a physician, most health insurance plans in the United States do not cover the cost of genetic testing. Coverage and reimbursement are completely determined by the provider's policy. For example, Medicare covers genetic testing for persons with cancer who qualify for Medicare coverage of genetic testing for an inherited mutation. Such worries are stifling market expansion throughout the world.
The segmentation coverage of the study is provided below.
Molecular Biology Enzymes and Kits & Reagents Market based on Product
- Kits and Reagents
- Enzymes
- Polymerases
- Ligases
- Restriction Endonucleases
- Reverse Transcriptases
- Others
- Polymerase Chain Reaction
- Sequencing
- Cloning
- Epigenetics
- Restriction Digestion
- Synthetic Biology
- Others
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Centers
- Others
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
- Latin America (LATAM)
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa (MEA)
- UAE
- Turkey
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Previously, North America led the worldwide Molecular Biology Enzymes, Kits, and Reagents market, with Europe close behind. Factors contributing to North American market domination include the availability of cutting-edge technology and the presence of better research institutes for R&D on enzymes and reagents. However, the expanding number of life science and drug discovery research, as well as important improvements in health and medicine in emerging nations, are expected to assist Asia Pacific grow significantly throughout the projection period.
The competitive landscape for molecular biology kits and reagents gives information by competitor. Company overview, financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance are all included. The data points shown above are only linked to the firms' concentration on the molecular biology kits and reagent sector.
Thermo Fisher Scientific, Inc., LGC Limited, Merck KGaA, Promega Corporation, New England Biolabs, Illumina, Inc., Takara Bio Inc., Qiagen, FUJIFILM, and others are among the prominent competitors profiled in the molecular biology kits and reagent market research. Among the local and worldwide companies are Wako Pure Chemical Corporation, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Sigma-Aldrich Co., Bio-Rad Laboratories, Inc., Bio Basic Inc., Jena Bioscience GmbH, BD, Abbott, Beckman Coulter, Inc., Life Technologies, and MBR, Inc. Global, North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America market share statistics are accessible individually. Analysts at DBMR evaluate competitive strengths and conduct competitive analysis for each rival individually.
- This report illustrates the most vital attributes of the Molecular Biology Enzymes and Kits & Reagents Market, which are driving and providing opportunities.
- This research gives an in-depth analysis of the Molecular Biology Enzymes and Kits & Reagents Market growth on the basis of several segments in the market.
- This report presents the predictions of the past and present trends of the Molecular Biology Enzymes and Kits & Reagents Market.
- This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Molecular Biology Enzymes and Kits & Reagents Market.
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. PRODUCT: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Kits and Reagents
5.3. Enzymes
5.4. Polymerases
5.5. Ligases
5.6. Restriction Endonucleases
5.7. Reverse Transcriptases
5.8. Others
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Polymerase Chain Reaction
6.3. Sequencing
6.4. Cloning
6.5. Epigenetics
6.6. Restriction Digestion
6.7. Synthetic Biology
6.8. Others
7. END USER: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Academic and Research Institutes
7.3. Pharmaceutical and Biotechnology Companies
7.4. Hospitals and Diagnostic Centers
7.5. Others
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. LGC LIMITED
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. PROMEGA CORPORATION
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. MERCK KGAA
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. NEW ENGLAND BIOLABS
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. ILLUMINA INC.
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. TAKARA BIO INC.
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. BIO-RAD LABORATORIES INC.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. THERMO FISHER SCIENTIFIC, INC.
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. F.HOFFMANN-LA ROCHE LTD.
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. QIAGEN
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
Tables
TABLE 1. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 2. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR KITS AND REAGENTS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR ENZYMES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR POLYMERASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR LIGASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR RESTRICTION ENDONUCLEASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR REVERSE TRANSCRIPTASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 8. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 10. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR SEQUENCING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 12. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR CLONING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 13. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR EPIGENETICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 14. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR RESTRICTION DIGESTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 15. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR SYNTHETIC BIOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 16. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 17. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR ACADEMIC AND RESEARCH INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 18. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 19. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 20. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 21. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 22. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 23. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 24. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 25. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 26. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 27. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 28. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 29. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 30. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 31. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 32. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 33. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 34. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 35. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 36. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 37. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 38. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 40. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 41. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 43. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 44. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 46. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 47. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 48. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 49. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 50. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 51. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 52. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 53. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 54. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 55. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 56. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 57. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 59. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 60. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 61. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 62. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 63. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 64. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 65. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 66. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 67. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 68. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 69. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 71. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 72. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 73. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 74. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 75. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 76. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 77. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 78. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 79. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 80. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 81. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 82. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 83. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 84. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 85. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 86. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 87. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 88. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 89. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 90. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 91. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 92. LGC LIMITED : FINANCIALS
TABLE 93. LGC LIMITED : PRODUCTS & SERVICES
TABLE 94. LGC LIMITED : RECENT DEVELOPMENTS
TABLE 95. PROMEGA CORPORATION: FINANCIALS
TABLE 96. PROMEGA CORPORATION: PRODUCTS & SERVICES
TABLE 97. PROMEGA CORPORATION: RECENT DEVELOPMENTS
TABLE 98. MERCK KGAA: FINANCIALS
TABLE 99. MERCK KGAA: PRODUCTS & SERVICES
TABLE 100. MERCK KGAA: RECENT DEVELOPMENTS
TABLE 101. NEW ENGLAND BIOLABS: FINANCIALS
TABLE 102. NEW ENGLAND BIOLABS: PRODUCTS & SERVICES
TABLE 103. NEW ENGLAND BIOLABS: RECENT DEVELOPMENTS
TABLE 104. ILLUMINA INC.: FINANCIALS
TABLE 105. ILLUMINA INC.: PRODUCTS & SERVICES
TABLE 106. ILLUMINA INC.: RECENT DEVELOPMENTS
TABLE 107. TAKARA BIO INC.: FINANCIALS
TABLE 108. TAKARA BIO INC.: PRODUCTS & SERVICES
TABLE 109. TAKARA BIO INC.: RECENT DEVELOPMENTS
TABLE 110. BIO-RAD LABORATORIES INC.: FINANCIALS
TABLE 111. BIO-RAD LABORATORIES INC.: PRODUCTS & SERVICES
TABLE 112. BIO-RAD LABORATORIES INC.: DEVELOPMENTS
TABLE 113. THERMO FISHER SCIENTIFIC, INC.: FINANCIALS
TABLE 114. THERMO FISHER SCIENTIFIC, INC.: PRODUCTS & SERVICES
TABLE 115. THERMO FISHER SCIENTIFIC, INC.: RECENT DEVELOPMENTS
TABLE 116. F.HOFFMANN-LA ROCHE LTD.: FINANCIALS
TABLE 117. F.HOFFMANN-LA ROCHE LTD.: PRODUCTS & SERVICES
TABLE 118. F.HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS
TABLE 119. QIAGEN: FINANCIALS
TABLE 120. QIAGEN: PRODUCTS & SERVICES
TABLE 121. QIAGEN: RECENT DEVELOPMENTS
Charts
CHART. 1. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 2. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR KITS AND REAGENTS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
CHART. 3. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR ENZYMES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 4. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR POLYMERASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 5. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR LIGASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 6. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR RESTRICTION ENDONUCLEASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 7. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR REVERSE TRANSCRIPTASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 8. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 9. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 10. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 11. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR SEQUENCING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 12. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR CLONING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 13. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR EPIGENETICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 14. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR RESTRICTION DIGESTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 15. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR SYNTHETIC BIOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 16. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 17. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR ACADEMIC AND RESEARCH INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 18. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 19. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 20. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 21. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 22. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 23. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 24. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 25. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 26. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 27. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 28. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 29. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 30. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 31. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 32. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 33. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 34. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 35. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 36. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 37. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 38. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 39. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 40. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 41. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 42. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 43. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 44. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 45. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 46. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 47. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 48. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 49. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 50. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 51. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 52. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 53. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 54. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 55. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 56. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 57. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 58. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 59. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 60. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 61. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 62. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 63. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 64. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 65. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 66. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 67. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 68. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 69. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 70. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 71. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 72. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 73. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 74. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 75. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 76. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 77. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 78. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 79. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 80. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 81. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 82. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 83. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 84. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 85. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 86. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 87. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 88. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 89. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 90. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 91. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 92. LGC LIMITED : FINANCIALS
CHART. 93. LGC LIMITED : PRODUCTS & SERVICES
CHART. 94. LGC LIMITED : RECENT DEVELOPMENTS
CHART. 95. PROMEGA CORPORATION: FINANCIALS
CHART. 96. PROMEGA CORPORATION: PRODUCTS & SERVICES
CHART. 97. PROMEGA CORPORATION: RECENT DEVELOPMENTS
CHART. 98. MERCK KGAA: FINANCIALS
CHART. 99. MERCK KGAA: PRODUCTS & SERVICES
CHART. 100. MERCK KGAA: RECENT DEVELOPMENTS
CHART. 101. NEW ENGLAND BIOLABS: FINANCIALS
CHART. 102. NEW ENGLAND BIOLABS: PRODUCTS & SERVICES
CHART. 103. NEW ENGLAND BIOLABS: RECENT DEVELOPMENTS
CHART. 104. ILLUMINA INC.: FINANCIALS
CHART. 105. ILLUMINA INC.: PRODUCTS & SERVICES
CHART. 106. ILLUMINA INC.: RECENT DEVELOPMENTS
CHART. 107. TAKARA BIO INC.: FINANCIALS
CHART. 108. TAKARA BIO INC.: PRODUCTS & SERVICES
CHART. 109. TAKARA BIO INC.: RECENT DEVELOPMENTS
CHART. 110. BIO-RAD LABORATORIES INC.: FINANCIALS
CHART. 111. BIO-RAD LABORATORIES INC.: PRODUCTS & SERVICES
CHART. 112. BIO-RAD LABORATORIES INC.: DEVELOPMENTS
CHART. 113. THERMO FISHER SCIENTIFIC, INC.: FINANCIALS
CHART. 114. THERMO FISHER SCIENTIFIC, INC.: PRODUCTS & SERVICES
CHART. 115. THERMO FISHER SCIENTIFIC, INC.: RECENT DEVELOPMENTS
CHART. 116. F.HOFFMANN-LA ROCHE LTD.: FINANCIALS
CHART. 117. F.HOFFMANN-LA ROCHE LTD.: PRODUCTS & SERVICES
CHART. 118. F.HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS
CHART. 119. QIAGEN: FINANCIALS
CHART. 120. QIAGEN: PRODUCTS & SERVICES
CHART. 121. QIAGEN: RECENT DEVELOPMENTS
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. PRODUCT: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Kits and Reagents
5.3. Enzymes
5.4. Polymerases
5.5. Ligases
5.6. Restriction Endonucleases
5.7. Reverse Transcriptases
5.8. Others
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Polymerase Chain Reaction
6.3. Sequencing
6.4. Cloning
6.5. Epigenetics
6.6. Restriction Digestion
6.7. Synthetic Biology
6.8. Others
7. END USER: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Academic and Research Institutes
7.3. Pharmaceutical and Biotechnology Companies
7.4. Hospitals and Diagnostic Centers
7.5. Others
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. LGC LIMITED
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. PROMEGA CORPORATION
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. MERCK KGAA
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. NEW ENGLAND BIOLABS
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. ILLUMINA INC.
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. TAKARA BIO INC.
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. BIO-RAD LABORATORIES INC.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. THERMO FISHER SCIENTIFIC, INC.
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. F.HOFFMANN-LA ROCHE LTD.
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. QIAGEN
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
Tables
TABLE 1. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 2. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR KITS AND REAGENTS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
TABLE 3. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR ENZYMES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 4. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR POLYMERASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR LIGASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR RESTRICTION ENDONUCLEASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 7. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR REVERSE TRANSCRIPTASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 8. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 9. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 10. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 11. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR SEQUENCING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 12. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR CLONING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 13. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR EPIGENETICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 14. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR RESTRICTION DIGESTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 15. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR SYNTHETIC BIOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 16. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 17. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR ACADEMIC AND RESEARCH INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 18. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 19. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 20. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 21. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 22. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 23. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 24. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 25. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 26. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 27. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 28. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 29. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 30. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 31. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 32. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 33. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 34. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 35. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 36. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 37. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 38. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 39. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 40. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 41. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 42. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 43. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 44. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 45. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 46. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 47. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 48. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 49. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 50. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 51. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 52. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 53. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 54. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 55. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
TABLE 56. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 57. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 58. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 59. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 60. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 61. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 62. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 63. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 64. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 65. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 66. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 67. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 68. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 69. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 70. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 71. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 72. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 73. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 74. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 75. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 76. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 77. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 78. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 79. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 80. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 81. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 82. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 83. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 84. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 85. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 86. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 87. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 88. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 89. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
TABLE 90. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
TABLE 91. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
TABLE 92. LGC LIMITED : FINANCIALS
TABLE 93. LGC LIMITED : PRODUCTS & SERVICES
TABLE 94. LGC LIMITED : RECENT DEVELOPMENTS
TABLE 95. PROMEGA CORPORATION: FINANCIALS
TABLE 96. PROMEGA CORPORATION: PRODUCTS & SERVICES
TABLE 97. PROMEGA CORPORATION: RECENT DEVELOPMENTS
TABLE 98. MERCK KGAA: FINANCIALS
TABLE 99. MERCK KGAA: PRODUCTS & SERVICES
TABLE 100. MERCK KGAA: RECENT DEVELOPMENTS
TABLE 101. NEW ENGLAND BIOLABS: FINANCIALS
TABLE 102. NEW ENGLAND BIOLABS: PRODUCTS & SERVICES
TABLE 103. NEW ENGLAND BIOLABS: RECENT DEVELOPMENTS
TABLE 104. ILLUMINA INC.: FINANCIALS
TABLE 105. ILLUMINA INC.: PRODUCTS & SERVICES
TABLE 106. ILLUMINA INC.: RECENT DEVELOPMENTS
TABLE 107. TAKARA BIO INC.: FINANCIALS
TABLE 108. TAKARA BIO INC.: PRODUCTS & SERVICES
TABLE 109. TAKARA BIO INC.: RECENT DEVELOPMENTS
TABLE 110. BIO-RAD LABORATORIES INC.: FINANCIALS
TABLE 111. BIO-RAD LABORATORIES INC.: PRODUCTS & SERVICES
TABLE 112. BIO-RAD LABORATORIES INC.: DEVELOPMENTS
TABLE 113. THERMO FISHER SCIENTIFIC, INC.: FINANCIALS
TABLE 114. THERMO FISHER SCIENTIFIC, INC.: PRODUCTS & SERVICES
TABLE 115. THERMO FISHER SCIENTIFIC, INC.: RECENT DEVELOPMENTS
TABLE 116. F.HOFFMANN-LA ROCHE LTD.: FINANCIALS
TABLE 117. F.HOFFMANN-LA ROCHE LTD.: PRODUCTS & SERVICES
TABLE 118. F.HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS
TABLE 119. QIAGEN: FINANCIALS
TABLE 120. QIAGEN: PRODUCTS & SERVICES
TABLE 121. QIAGEN: RECENT DEVELOPMENTS
Charts
CHART. 1. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 2. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR KITS AND REAGENTS, BY GEOGRAPHY , 2021-2030 (USD BILLION)
CHART. 3. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR ENZYMES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 4. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR POLYMERASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 5. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR LIGASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 6. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR RESTRICTION ENDONUCLEASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 7. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR REVERSE TRANSCRIPTASES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 8. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 9. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 10. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 11. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR SEQUENCING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 12. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR CLONING, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 13. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR EPIGENETICS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 14. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR RESTRICTION DIGESTION, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 15. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR SYNTHETIC BIOLOGY, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 16. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 17. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR ACADEMIC AND RESEARCH INSTITUTES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 18. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 19. MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
CHART. 20. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 21. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 22. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 23. NORTH AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 24. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 25. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 26. U.S MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 27. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 28. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 29. CANADA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 30. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 31. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 32. MEXICO MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 33. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 34. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 35. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 36. EUROPE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 37. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 38. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 39. GERMANY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 40. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 41. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 42. U.K MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 43. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 44. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 45. FRANCE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 46. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 47. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 48. ITALY MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 49. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 50. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 51. SPAIN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 52. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 53. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 54. ROE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 55. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION)
CHART. 56. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 57. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 58. ASIA PACIFIC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 59. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 60. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 61. CHINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 62. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 63. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 64. INDIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 65. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 66. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 67. JAPAN MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 68. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 69. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 70. REST OF APAC MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 71. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 72. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 73. LATIN AMERICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 74. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 75. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 76. BRAZIL MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 77. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 78. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 79. ARGENTINA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 80. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 81. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 82. MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 83. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 84. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 85. SAUDI ARABIA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 86. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 87. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 88. UAE MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 89. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY PRODUCT, 2021-2030 (USD BILLION)
CHART. 90. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION)
CHART. 91. REST OF MIDDLE EAST AND AFRICA MOLECULAR BIOLOGY ENZYMES AND KITS & REAGENTS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION)
CHART. 92. LGC LIMITED : FINANCIALS
CHART. 93. LGC LIMITED : PRODUCTS & SERVICES
CHART. 94. LGC LIMITED : RECENT DEVELOPMENTS
CHART. 95. PROMEGA CORPORATION: FINANCIALS
CHART. 96. PROMEGA CORPORATION: PRODUCTS & SERVICES
CHART. 97. PROMEGA CORPORATION: RECENT DEVELOPMENTS
CHART. 98. MERCK KGAA: FINANCIALS
CHART. 99. MERCK KGAA: PRODUCTS & SERVICES
CHART. 100. MERCK KGAA: RECENT DEVELOPMENTS
CHART. 101. NEW ENGLAND BIOLABS: FINANCIALS
CHART. 102. NEW ENGLAND BIOLABS: PRODUCTS & SERVICES
CHART. 103. NEW ENGLAND BIOLABS: RECENT DEVELOPMENTS
CHART. 104. ILLUMINA INC.: FINANCIALS
CHART. 105. ILLUMINA INC.: PRODUCTS & SERVICES
CHART. 106. ILLUMINA INC.: RECENT DEVELOPMENTS
CHART. 107. TAKARA BIO INC.: FINANCIALS
CHART. 108. TAKARA BIO INC.: PRODUCTS & SERVICES
CHART. 109. TAKARA BIO INC.: RECENT DEVELOPMENTS
CHART. 110. BIO-RAD LABORATORIES INC.: FINANCIALS
CHART. 111. BIO-RAD LABORATORIES INC.: PRODUCTS & SERVICES
CHART. 112. BIO-RAD LABORATORIES INC.: DEVELOPMENTS
CHART. 113. THERMO FISHER SCIENTIFIC, INC.: FINANCIALS
CHART. 114. THERMO FISHER SCIENTIFIC, INC.: PRODUCTS & SERVICES
CHART. 115. THERMO FISHER SCIENTIFIC, INC.: RECENT DEVELOPMENTS
CHART. 116. F.HOFFMANN-LA ROCHE LTD.: FINANCIALS
CHART. 117. F.HOFFMANN-LA ROCHE LTD.: PRODUCTS & SERVICES
CHART. 118. F.HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS
CHART. 119. QIAGEN: FINANCIALS
CHART. 120. QIAGEN: PRODUCTS & SERVICES
CHART. 121. QIAGEN: RECENT DEVELOPMENTS
